Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014)

Tandem Diabetes Care (TNDM) posted Non Operating Investment Income of $6529.0 for Q3 2014, up 520.95% on a QoQ basis from -$1551.0 in Q2 2014.

Tandem Diabetes Care (TNDM) Non Operating Investment Income (2014) Analysis & Trends

Tandem Diabetes Care's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $6529.0 for Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-
10	Tandem Diabetes Care	1.17 Bn	597.96 Mn	136.79 Mn	-

Download Data